$5.60 0.00 (0%)
3/23/2009 4:00 PM

Indevus Pharmaceuticals (IDEV.DL)

CAPS Rating: No stars

A biopharmaceutical company engaged in the acquisition, development and commercialization of products to treat urological, gynecological and men's health conditions.

Recs

1
Member Avatar mellster (78.94) Submitted: 10/30/2008 1:20:30 PM : Outperform Start Price: $2.11 IDEV.DL Score: +170.33

Lots of drugs on the market already that generate substantial revenues, Nebido (blockbuster testosterone drug) approval in reach, Pagoclone and Valstar updates in the near-term are likely.

Report this Post 0 Comments

Featured Broker Partners